Abiraterone Acetate Tablet
Product Images NDC 60505-4327

6 FDA label images from Apotex Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 60505-4327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A survival curve graph showing the percentage of subjects without death over time in months from randomization. Two curves compare abiraterone acetate and placebo groups, depicting a decline in survival percentage for both over 60 months.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A Kaplan-Meier survival curve graph showing the percentage of subjects without radiographic progression or death over time following randomization, comparing Abiraterone Acetate and placebo groups. The x-axis represents months from randomization, and the y-axis shows the percentage of subjects without progression or death. Lines represent survival for each group, with corresponding subject numbers at risk indicated below the x-axis.*
FDA Label Image

Figure 4

Figure 4
A Kaplan-Meier survival curve chart comparing the percentage survival of subjects without death over months from randomization between Abiraterone acetate and Placebo groups. The x-axis shows months from randomization up to 72 months, and the y-axis shows the percentage survival from 0% to 100%. The chart includes data points for subjects at risk in each group during the study period, with Abiraterone acetate represented by a solid line with circles and Placebo by a dashed line with triangles, illustrating higher survival in the Abiraterone acetate group.*
FDA Label Image

Figure 1 (Graph 1)

Figure 1 (Graph 1)
A survival curve chart comparing the percentage survival over time in months between Abiraterone Acetate and Placebo groups. The x-axis represents time to death in months, and the y-axis shows percentage survival, illustrating survival trends for each group.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Abiraterone Acetate, showing its steroidal nucleus and acetate functional group attached, as well as a pyridine ring. The black and white diagram depicts carbon, hydrogen, oxygen, and nitrogen atoms with associated bonds.*
FDA Label Image

Container-label-250mg (Container Label 250mg)

Container-label-250mg (Container Label 250mg)
Label for Abiraterone Acetate Tablets, USP, 250 mg, oral tablets. The package contains 120 tablets. Manufactured by Apotex Inc., Toronto, Ontario, and labeled for Apotex Corp., Weston, Florida. The label includes storage instructions, a warning for pregnant women, dispensing information, and a barcode. Product NDC is 60505-4327-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.